JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

Cytek Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

4.46 -0.89

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.35

Max

4.49

Pagrindiniai rodikliai

By Trading Economics

Pajamos

105K

-5.5M

Pardavimai

6.7M

52M

Pelnas, tenkantis vienai akcijai

-0

Pelno marža

-10.476

Darbuotojai

692

EBITDA

6.4M

-4.2M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+37.11% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-26

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

159M

660M

Ankstesnė atidarymo kaina

5.35

Ankstesnė uždarymo kaina

4.46

Naujienos nuotaikos

By Acuity

17%

83%

20 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Cytek Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-06 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-06 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-06 21:40; UTC

Įsigijimai, susijungimai, perėmimai

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

2026-02-06 21:22; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Accelerating in January -- Market Talk

2026-02-06 21:17; UTC

Uždarbis

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026-02-06 21:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-02-06 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

2026-02-06 21:13; UTC

Uždarbis

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

2026-02-06 21:13; UTC

Uždarbis

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

2026-02-06 21:04; UTC

Rinkos pokalbiai

Gold Closes Out Volatile Week on Higher Note -- Market Talk

2026-02-06 20:34; UTC

Uždarbis

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

2026-02-06 20:27; UTC

Uždarbis

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

2026-02-06 20:24; UTC

Rinkos pokalbiai

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

2026-02-06 20:20; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

2026-02-06 19:48; UTC

Uždarbis

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

2026-02-06 19:30; UTC

Įsigijimai, susijungimai, perėmimai

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

2026-02-06 19:30; UTC

Įsigijimai, susijungimai, perėmimai

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

2026-02-06 19:30; UTC

Įsigijimai, susijungimai, perėmimai

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

2026-02-06 19:17; UTC

Rinkos pokalbiai

USDA Says Farm Income to Decrease in 2026 -- Market Talk

2026-02-06 18:50; UTC

Uždarbis

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026-02-06 18:47; UTC

Rinkos pokalbiai

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

2026-02-06 18:34; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

2026-02-06 17:58; UTC

Uždarbis

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

2026-02-06 17:52; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2026-02-06 17:52; UTC

Rinkos pokalbiai
Uždarbis

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

2026-02-06 17:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-02-06 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-06 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-06 17:18; UTC

Rinkos pokalbiai

Canada's Bizarre Jobs Report Points to Growing Labor Slack -- Market Talk

2026-02-06 17:09; UTC

Rinkos pokalbiai

Dollar on Path to Snap Weekly Losing Streak -- Market Talk

Akcijų palyginimas

Kainos pokytis

Cytek Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

37.11% į viršų

12 mėnesių prognozė

Vidutinis 6.17 USD  37.11%

Aukščiausias 7.5 USD

Žemiausias 5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Cytek Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

1

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

3.7 / 3.8Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

20 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat